Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
07/2004
07/01/2004US20040126898 Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (ANCA)
07/01/2004US20040126870 Ncc2705-the genome of a bifodobacterium
07/01/2004US20040126867 Human RNase III and compositions and uses thereof
07/01/2004US20040126846 Endogenous granzyme B in non-immune cells
07/01/2004US20040126845 Nucleotide sequences comprising regulatory elements which simultaneously enhance the expression of a first RNA sequence and at the same time as suppress the expression of a second RNA sequences; gene expression inhibition
07/01/2004US20040126839 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/01/2004US20040126807 Isolated nucleic acids; polypeptides showing higher expression on cancer cells
07/01/2004US20040126803 Method for profiling and identifying persons by using data samples
07/01/2004US20040126792 Inhibiting ribosome peptide synthesis; high throughput screening for peptidyl transferase modulators; kits
07/01/2004US20040126783 Apparatus and method for isolating a nucleic acid from a sample
07/01/2004US20040126775 Detection of survivin in the biological fluids of cancer patients
07/01/2004US20040126771 PRNA chimera
07/01/2004US20040126761 Modulation of alpha-methylacyl-CoA racemase expression
07/01/2004US20040126757 Method and apparatus for synthesis of arrays of DNA probes
07/01/2004US20040126752 High RNA binding affinity to complementary nucleic acids and are base and acid stable; treatment of cancer, viral infections
07/01/2004US20040126391 Meningococcal antigens
07/01/2004US20040126390 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
07/01/2004DE10361928A1 Analyzing the condition of the uterine mucosa, useful for assessing endometrial receptivity or diagnosing uterine tumor, based on measuring expression of specific beta subunits of chorionic gonadotrophin
07/01/2004DE10260592A1 New 2-(1-((hetero)aryl(oxy))-ethyl)-nitrobenzene derivatives, useful for introducing intramolecular triplet sensitized photolabile protecting groups into synthons for light-controlled biopolymer production
07/01/2004DE10260591A1 Stepwise synthesis of biopolymer, e.g. nucleic acid, using synthons having two-stage protecting group activated by cleavage of triplet-sensitized and/or labeled photoactivatable group to allow quality control
07/01/2004CA2808592A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome
07/01/2004CA2808584A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome
07/01/2004CA2808318A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome
07/01/2004CA2808190A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome
07/01/2004CA2509520A1 Identification of oligonucleotides for the capture, detection and quantitation of west nile virus
06/2004
06/30/2004EP1433846A2 Phagemid-based method of producing filamentous bacteriophage particles displaying antibody molecules and the corresponding bacteriophage particles.
06/30/2004EP1433844A2 Novel recombinant xylanases derived from anaerobic fungi, and the relevant sequences, expression vectors and hosts
06/30/2004EP1432824A2 Compositions and methods relating to prostate specific genes and proteins
06/30/2004EP1432818A1 Nucleic acid archiving
06/30/2004EP1432724A1 Rna interference mediated inhibition of map kinase genes
06/30/2004EP1432723A2 Modulation of the expression of genes dependent on stat-1
06/30/2004EP1390545A4 Biological sample processing methods and compositions that include surfactants
06/30/2004EP1366197A4 Methods and compositions for amplification of rna sequences
06/30/2004EP1127161A4 Method for making complementary oligonucleotide tag sets
06/30/2004EP1112366B1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses
06/30/2004EP0977769B1 A process for the synthesis of modified p-chiral nucleotide analogues
06/30/2004EP0686161B1 Novel human beta2 integrin alpha subunit
06/30/2004EP0564532B1 Polypeptides derived from proteins of the hepatitis c virus
06/30/2004CN1508251A Malignant malarial parasite msra-3 gene, protein product and use thereof
06/30/2004CN1508250A Malignant malarial parasite msra-2 gene, protein product and use thereof
06/30/2004CN1508249A Maiignant malarial parasite msra-1 gene, protein product and use thereof
06/30/2004CN1508248A Tumour related gene and use thereof
06/30/2004CN1508143A Contruction of cDNA library of cell differential expression using LCM technology and rat testicular specific gene RSD-6 cloning and biolobical function
06/30/2004CN1508142A Human Testicular specific gene VCX-8r and VCY coding protein biological function
06/30/2004CN1155720C Nucleic acid molecular probe for identifying blue-green alga and method
06/30/2004CN1155710C Recombinant herpesvirus with the use of gB Gene promoter
06/30/2004CN1155704C Specific augmentation primer and its method of labelling wheat macromolecular glutelin subunit
06/30/2004CN1155616C Human protein with cancer cell growth promoting function and its coding sequence
06/30/2004CN1155615C Human protein with cancer cell growth suppressing function and its coding sequence
06/30/2004CN1155614C Human protein with cancer cell growth suppressing function and its coding sequence
06/30/2004CN1155613C Human tumor associated gene in 1-zone 3-band 3-subband of short arm of human chromosome No. 17 and its coding protein
06/29/2004US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain
06/29/2004US6756495 Method for detecting the presence of biological matters of bovine origin, and oligonucleotides for its implementation
06/29/2004US6756492 Used for sequencing nucleic acids efficiently; photolabile group contains 2-nitrophenyl moiety
06/29/2004CA2131311C Covalently cross-linked oligonucleotides
06/29/2004CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas)
06/27/2004CA2451588A1 Protein having active sulfate transporter activity and method for detecting canceration of tissue
06/24/2004WO2004053169A1 Modulation of interleukin 18 expression
06/24/2004WO2004053143A2 Concurrent enzymatic polynucleotide synthesis and detectable signal generation
06/24/2004WO2004053142A2 P53-associated parkin-like cytoplasmic protein, and related compositions and methods
06/24/2004WO2004053141A2 Methods for rapid forensic analysis of mitochondrial dna and characterization of mitochondrial dna heteroplasmy
06/24/2004WO2004053104A2 5’ cpg nucleic acids and methods of use
06/24/2004WO2004053065A2 Disorazole polyketide synthase encoding polynucleotides
06/24/2004WO2004053061A2 Methods of therapy and diagnosis using targeting of cells that express lax
06/24/2004WO2004052910A1 A full-length polynucleotide coding chicken type ii collagen and the use of it
06/24/2004WO2004052907A1 Nucleic acid labeling compounds
06/24/2004WO2004052309A2 Modulation of stat 6 expression
06/24/2004WO2004052306A2 Modulation of ppar-alpha expression
06/24/2004WO2004052301A2 Modulation of matrix metalloproteinase 11 expression
06/24/2004WO2004052300A2 Modulation of alpha-methylacyl-coa racemase expression
06/24/2004WO2004052293A2 Recombinant vaccine against flavivirus infection
06/24/2004WO2004052290A2 Compositions, splice variants and methods relating to breast specific genes and proteins
06/24/2004WO2004052175A2 Methods for rapid identification of pathogens in humans and animals
06/24/2004WO2004007748A3 Deprotection and purification of oligonucleotides and their derivatives
06/24/2004WO2004003514A3 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
06/24/2004WO2002092766A3 Compositions and methods for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences
06/24/2004US20040122211 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/24/2004US20040121973 For therapy of cancer and diabetes
06/24/2004US20040121970 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
06/24/2004US20040121959 Comprises cyclic amino acid sequences for use in treatment and prevention of nervous system, inflammatory, pain, asthmatic, urogenital, skin and cancer disorders
06/24/2004US20040121948 Methods and materials relating to semaphorin-like polypeptides and polynucleotides
06/24/2004US20040121433 P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
06/24/2004US20040121387 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders
06/24/2004US20040121386 Comprises nucleotide sequences coding mitogen-activated protein kinase kinases 7 (MKK7) for diagnosis and treatment of inflammatory and cancer disorders
06/24/2004US20040121371 Use of fluorescent moieties and flap endonuclease to quantify and identify preferential nucleotide sequences in mixed solution
06/24/2004US20040121370 Novel composition and methods for the treatment of immune related diseases
06/24/2004US20040121367 Primers and primer sets for use in methods to detect the presence of Acidovorax avenae subsp. citrulli
06/24/2004US20040121365 Double and triple readout assay systems
06/24/2004US20040121361 Nucleic acid-associated proteins
06/24/2004US20040121352 exhibits substantial acid resistance, allowing the arrays to be treated with low pH solutions; solid phase synthesis
06/24/2004US20040121351 for diagnosing polymorphism in a tubulin molecule and for anticancer drug screening
06/24/2004US20040121335 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS)
06/24/2004US20040121328 Modulation of phosphodiesterase 8A Expression
06/24/2004US20040121313 Methods for rapid detection and identification of bioagents in organs for transplantation
06/24/2004US20040121311 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS)
06/24/2004US20040121309 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS)
06/24/2004US20040120957 Use of A33 antigens JAM-it
06/24/2004US20040120939 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
06/24/2004CA2510007A1 Methods for rapid forensic analysis of mitochondrial dna and characterization of mitochondrial dna heteroplasmy
06/24/2004CA2508584A1 Methods for rapid identification of pathogens in humans and animals